Gene · 1893
Papers1,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nobiletin and polydatin synergistically alleviate triple-negative breast cancer liver metastasis via suppressing ECM1a-mediated fatty acid biosynthesis. | Acta Pharmacol Sin | 2026 | 41083594 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| The correlation between serum ECM1 and cardiac fibrosis in heart failure patients. | BMC Cardiovasc Disord | 2025 | 41361743 | PubTator, text mining | PubMed |
| Opportunities and Risks of Promoting Skin and Bone Healing via Implant Biofunctionalization of Extracellular Matrix Protein ECM1. | J Funct Biomater | 2025 | 41149731 | PubTator, text mining | PubMed |
| Artificial Intelligence-Assisted Nanosensors for Clinical Diagnostics: Current Advances and Future Prospects. | Biosensors (Basel) | 2025 | 41149307 | PubTator, text mining | PubMed |
| Regenerative Approaches in Vulvar Lichen Sclerosus: A Systematic Review. | Int J Mol Sci | 2025 | 41009377 | PubTator, text mining | PubMed |
| Exploring Genital Lichen Sclerosus: Navigating from Pathophysiology to Precise Diagnostic Approaches. | Biomedicines | 2025 | 41007812 | PubTator, text mining | PubMed |
| Extracellular matrix protein 1 in cancer: multifaceted roles in tumor progression, prognosis, and therapeutic targeting. | Arch Pharm Res | 2025 | 40996600 | PubTator, text mining | PubMed |
| Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface. | Front Immunol | 2025 | 40948775 | PubTator, text mining | PubMed |
| The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. | Elife | 2025 | 40878909 | PubTator, text mining | PubMed |
| ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas. | NPJ Precis Oncol | 2025 | 40866630 | PubTator, text mining | PubMed |
| Identification and validation of ECM1 as a causal plasma biomarker in knee osteoarthritis through proteome-wide association study and bioinformatics. | Medicine (Baltimore) | 2025 | 40859530 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields macrophage-secreted drivers of invasion. | JCI Insight | 2025 | 40857405 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlation in Lipoid Proteinosis: 15 Cases from Turkiye. | Mol Syndromol | 2025 | 40771186 | PubTator, text mining | PubMed |
| Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia. | Ann Hematol | 2025 | 40670727 | PubTator, text mining | PubMed |
| Five-Gene Expression Formula Accurately Detects Hepatocellular Carcinoma Tumors. | Biotechnol J | 2025 | 40629990 | PubTator, text mining | PubMed |
| Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple-Negative Breast Cancer. | J Extracell Vesicles | 2025 | 40545963 | PubTator, text mining | PubMed |
| Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility. | Eur Thyroid J | 2025 | 40440326 | PubTator, text mining | PubMed |
| Identification of signature genes and relationship with immune cell infiltration in intervertebral disc degeneration. | Front Genet | 2025 | 40270539 | PubTator, text mining | PubMed |
| Clinicopathological Challenge: Five Males Presenting With Progressive Skin Thickening and Hoarse Voices. | Int J Dermatol | 2025 | 40248982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1893/papers?page=3